Verified Data Provider
Optimized for quick response
Global Pricing Innovations Data Products: APIs & Datasets
Global Pricing Innovations Pricing & Cost
The supported pricing models for Global Pricing Innovations’ data are available by getting in contact with us via Datarade.
Additionally, GPI offer free data samples for the following:
- Pricing
- Cost of Treatment
- Reimbursement and HTA
Contact us now to find out more.
Global Pricing Innovations Reviews
Your Review
There are still only a few reviews and ratings for Global Pricing Innovations at the moment. Have you worked with Global Pricing Innovations? You can help other data professionals better understand Global Pricing Innovations’ data products and services by leaving a review now.
Global Pricing Innovations Competitors & Alternatives
USA
USA
USA
USA
About Global Pricing Innovations
Global Pricing Innovations in a Nutshell
GPI is a market leader in analytics and innovative solutions for biopharma pricing and market access. Founded in 2015 and headquartered London, GPI support price decision-making throughout the lifecycle and help the industry achieve day-to-day operational improvement and market access excellence.
As a team of leading domain specialists, GPI provide high quality, curated insights and recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception and payer behaviour. GPI’s suite of technology and bespoke service offerings are all powered by their dynamic analytics platform, GPI pulse.
By harnessing the power of technology, data, and collective expertise, GPI drives effective and efficient access to medicines with faster insights and sustainable pricing strategies.
To find out more about GPI, visit www.globalpricing.com.
Country Coverage
Data Offering
Drug costs: average cost to treat a patient per day/month/annum by indication/label
Drug Price and Reimbursement: list and visible net pricing data with payer compensation and restrictions, at pack level across 90+ markets. Historical data across all markets, with an average of 5 years.
HTA: decisions and drivers across 25 countries
Regulatory: official labels, regulatory information, launch dates
Policy and IRP: legislative updates impacting P&R
Use Cases
Early Development – Evaluating Commercial Potential
Our client was looking for a different set of inputs to justify price levels in price negotiation, as well as sense-checking the findings from more traditional pricing research such as payer and KOL interviews.
GPI leveraged an in-house price model that considered analogue information, retrospective HTA outcomes, SoC and competitors to asses the relationship between HTA and pricing as well as provide insights into price positioning and an understanding of value drivers.
Based on GPI’s model, the client gained an evidence-based insight into how HTA and prices may be linked. The findings from the analysis provided a clear outline of key analogue value – price relationships and helped our client to complete the strategic puzzle to position and optimise list prices and anticipate net pricing.
Pre-Launch - Commercial Forecasting
The project brief was to address several different forecasting needs to capture all aspects of a global product launch across multiple indications and patient groups. Our client was particularly looking to obtain a tool to address financial, market access as well as manufacturing forecasting needs across launch and beyond.
GPI created a global commercial forecast model in Excel that was flexible to incorporate several indications, distinguish different patient groups and market requirements. Competitor assumption, market access programmes and pricing approaches were incorporated. The tool provided sales, revenues and demand modelling as well as scenario analyses with monthly and yearly outputs.
The model provided our client with powerful insights to estimate sales and revenue, plan for demand and manufacturing. Model outputs were used for senior management reporting, budgeting, launch and manufacturing planning. Additionally, scenarios analysis helped to evaluate different commercial strategies. The model was flexible enough to be updated and adjust as launch progressed.
Launch
Finalize pricing policy/optimize launch
Our client was launching a new drug in phase III in a crowded space and need reliable and timely insights to stay ahead of the market.
Scope: 50 countries
Using GPI pulse, the company was able to review all pricing, reimbursement, regulatory and market access insights for drugs already launched with same mechanism of action and indication.
The client was able to determine the pricing and access landscape with detailed descriptions of gold standards and benchmarks against peers and best practice companies.
Client had a robust understanding of the data and arguments presented and payer decisions at the click of the button.
The insights enabled decision making and helped the client understand pricing, endpoints, comparators, payer interests and cost of each treatment option saving time and cost of a consulting engagement.
Data Sources & Collection
Our data is gathered from hundreds of underlying public and private sources globally.
Automatic collection of newly published information ensures the most up-to-date price and market access data.
The disparate sources of data are then
standardised to ensure analysis-ready data with seamless comparability across markets.
Key Differentiators
GPI is renowned for offering a bespoke, comprehensive solution for pricing and market access strategy. Combining robust, reliable data with domain expertise across the team, we are uniquely positioned to deliver insights powered by analytical approaches.
Through our intelligent algorithms powered by unrivalled integration of multiple global data sources, our technology offering reduces research time required to make informed decisions. In addition, our team of price and market access experts, allow us to create an analytical personalised case-by-case approach with each evidence-based strategy. In combination, these services are designed to support assets and pipeline development across the full product lifecycle.
GPI’s analytics platform, pulse™ 2.0, offers a unique insight into market access by integrating price, reimbursement, treatment cost, regulatory, and HTA decisions. Providing global coverage of over 95 countries as well as the most accurate prices across the supply chain, the latest version of the platform helps to deliver robust price and market access insights. Further features of the platform support specific business activities, including:
• Identifying the most relevant analogs for your assets
• Analysing historical pricing and market access journeys
• Monitoring competitive landscapes with real-time data
• Understanding key decisions drivers for commercial access
• Evaluating price and access potential for quick go/no-go decisions
Data Privacy
GPI is committed to ensuring that your privacy is protected. Should we ask you to provide certain information by which you can be identified with when using our website, mobile and other applications owned and operated by GPI, then you can be assured that it will only be used in accordance with this privacy statement.
Frequently asked questions about Global Pricing Innovations
What does Global Pricing Innovations do?
GPI is a market leader in analytics and innovative solutions for biopharma pricing and market access. Founded in 2015 and headquartered London, GPI support price decision-making throughout the lifecycle and help the industry achieve day-to-day operational improvement and market access excellence.
How much does Global Pricing Innovations cost?
The supported pricing models for Global Pricing Innovations’ data are available by getting in contact with them via Datarade. Global Pricing Innovations offers free samples for individual data requirements. Get talking to a member of the Global Pricing Innovations team to receive custom pricing options, information about data subscription fees, and quotes for Global Pricing Innovations’ data offering tailored to your use case.
What kind of data does Global Pricing Innovations have?
Pharma Data and Healthcare Industry Leads Data
What data does Global Pricing Innovations offer?
Drug costs: average cost to treat a patient per day/month/annum by indication/label Drug Price and Reimbursement: list and visible net pricing data with payer compensation and restrictions, at pack level across 90+ markets. Historical data across all markets, with an average of 5 years. HTA: decisions and drivers across 25 countries Regulatory: official labels, regulatory information, launch dates Policy and IRP: legislative updates impacting P&R
How does Global Pricing Innovations collect data?
Our data is gathered from hundreds of underlying public and private sources globally. Automatic collection of newly published information ensures the most up-to-date price and market access data. The disparate sources of data are then standardised to ensure analysis-ready data with seamless comparability across markets.
What’s Global Pricing Innovations’ data privacy policy?
GPI is committed to ensuring that your privacy is protected. Should we ask you to provide certain information by which you can be identified with when using our website, mobile and other applications owned and operated by GPI, then you can be assured that it will only be used in accordance with this privacy statement.
What are the best use cases for Global Pricing Innovations’ data?
Early Development – Evaluating Commercial Potential Our client was looking for a different set of inputs to justify price levels in price negotiation, as well as sense-checking the findings from more traditional pricing research such as payer and KOL interviews. GPI leveraged an in-house price model that considered analogue information, retrospective HTA outcomes, SoC and competitors to asses the relationship between HTA and pricing as well as provide insights into price positioning and an understanding of value drivers. Based on GPI’s model, the client gained an evidence-based insight into how HTA and prices may be linked. The findings from the analysis provided a clear outline of key analogue value – price relationships and helped our client to complete the strategic puzzle to position and optimise list prices and anticipate net pricing. Pre-Launch - Commercial Forecasting The project brief was to address several different forecasting needs to capture all aspects of a global product launch across multiple indications and patient groups. Our client was particularly looking to obtain a tool to address financial, market access as well as manufacturing forecasting needs across launch and beyond. GPI created a global commercial forecast model in Excel that was flexible to incorporate several indications, distinguish different patient groups and market requirements. Competitor assumption, market access programmes and pricing approaches were incorporated. The tool provided sales, revenues and demand modelling as well as scenario analyses with monthly and yearly outputs. The model provided our client with powerful insights to estimate sales and revenue, plan for demand and manufacturing. Model outputs were used for senior management reporting, budgeting, launch and manufacturing planning. Additionally, scenarios analysis helped to evaluate different commercial strategies. The model was flexible enough to be updated and adjust as launch progressed. Launch Finalize pricing policy/optimize launch Our client was launching a new drug in phase III in a crowded space and need reliable and timely insights to stay ahead of the market. Scope: 50 countries Using GPI pulse, the company was able to review all pricing, reimbursement, regulatory and market access insights for drugs already launched with same mechanism of action and indication. The client was able to determine the pricing and access landscape with detailed descriptions of gold standards and benchmarks against peers and best practice companies. Client had a robust understanding of the data and arguments presented and payer decisions at the click of the button. The insights enabled decision making and helped the client understand pricing, endpoints, comparators, payer interests and cost of each treatment option saving time and cost of a consulting engagement.